NCT00651313View on ClinicalTrials.gov

Efficacy and Safety Study of Lidocaine Vaginal Gel for Recurrent Dysmenorrhea (Painful Periods)

PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

August 31, 2008

Conditions
Dysmenorrhea
Interventions
DRUG

Lidocaine

Lidocaine vaginal gel 10% (150mg) administered once daily for 4 days

DRUG

Placebo

Placebo vaginal gel administered once daily for 4 days

Trial Locations (4)

27103

Lyndhurst Gynecologic Associates, Winston-Salem

38120

SCIREX Research Center, Memphis

78705

SCIREX Research Center, Austin

84124

Jean Brown Research, Salt Lake City

Sponsors
All Listed Sponsors
lead

Juniper Pharmaceuticals, Inc.

INDUSTRY